Shielding south african youth from HIV prevention myths
NCT ID NCT07518914
First seen Apr 23, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study tests whether a brief 'psychological inoculation' message can help young women in South Africa resist false claims about lenacapavir, a new twice-yearly injection that prevents HIV. About 1,500 women aged 18-29 will be randomly assigned to receive either the inoculation message or no message, then exposed to misinformation. The goal is to see if the inoculation protects their intention to use lenacapavir.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MISINFORMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Health Economics and Epidemiology Research Office, University of the Witwatersrand
Johannesburg, South Africa
Conditions
Explore the condition pages connected to this study.